ID   KAT3_RAT                Reviewed;         454 AA.
AC   Q58FK9;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 1.
DT   24-JUL-2024, entry version 99.
DE   RecName: Full=Kynurenine--oxoglutarate transaminase 3 {ECO:0000250|UniProtKB:Q71RI9};
DE            EC=2.6.1.7 {ECO:0000250|UniProtKB:Q71RI9};
DE   AltName: Full=Cysteine-S-conjugate beta-lyase 2 {ECO:0000250|UniProtKB:Q71RI9};
DE            EC=4.4.1.13 {ECO:0000250|UniProtKB:Q71RI9};
DE   AltName: Full=Kynurenine aminotransferase 3 {ECO:0000312|RGD:1359262};
DE   AltName: Full=Kynurenine aminotransferase III;
DE            Short=KATIII;
DE   AltName: Full=Kynurenine--glyoxylate transaminase {ECO:0000250|UniProtKB:Q71RI9};
DE            EC=2.6.1.63 {ECO:0000250|UniProtKB:Q71RI9};
DE   AltName: Full=Kynurenine--oxoglutarate transaminase III;
GN   Name=Kyat3 {ECO:0000312|RGD:1359262}; Synonyms=Ccbl2, Kat3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=16376499; DOI=10.1016/j.gene.2005.09.034;
RA   Yu P., Li Z., Zhang L., Tagle D.A., Cai T.;
RT   "Characterization of kynurenine aminotransferase III, a novel member of a
RT   phylogenetically conserved KAT family.";
RL   Gene 365:111-118(2006).
CC   -!- FUNCTION: Catalyzes the irreversible transamination of the L-tryptophan
CC       metabolite L-kynurenine to form kynurenic acid (KA), an intermediate in
CC       the tryptophan catabolic pathway which is also a broad spectrum
CC       antagonist of the three ionotropic excitatory amino acid receptors
CC       among others. May catalyze the beta-elimination of S-conjugates and Se-
CC       conjugates of L-(seleno)cysteine, resulting in the cleavage of the C-S
CC       or C-Se bond. Has transaminase activity towards L-kynurenine,
CC       tryptophan, phenylalanine, serine, cysteine, methionine, histidine,
CC       glutamine and asparagine with glyoxylate as an amino group acceptor (in
CC       vitro). Has lower activity with 2-oxoglutarate as amino group acceptor
CC       (in vitro). {ECO:0000250|UniProtKB:Q71RI9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-kynurenine = H2O + kynurenate + L-
CC         glutamate; Xref=Rhea:RHEA:65560, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:29985, ChEBI:CHEBI:57959,
CC         ChEBI:CHEBI:58454; EC=2.6.1.7;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65561;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glyoxylate + L-kynurenine = glycine + H2O + kynurenate;
CC         Xref=Rhea:RHEA:65896, ChEBI:CHEBI:15377, ChEBI:CHEBI:36655,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.63;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65897;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-hydroxy-L-kynurenine + glyoxylate = glycine + H2O +
CC         xanthurenate; Xref=Rhea:RHEA:65900, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:58125,
CC         ChEBI:CHEBI:71201; EC=2.6.1.63;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65901;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted L-cysteine + H2O = a thiol + NH4(+) +
CC         pyruvate; Xref=Rhea:RHEA:18121, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:28938, ChEBI:CHEBI:29256, ChEBI:CHEBI:58717; EC=4.4.1.13;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18122;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250|UniProtKB:Q71RI9};
CC   -!- PATHWAY: Amino-acid degradation; L-kynurenine degradation; kynurenate
CC       from L-kynurenine: step 1/2. {ECO:0000250|UniProtKB:Q71RI9}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q71RI9}.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY955395; AAX55607.1; -; mRNA.
DR   RefSeq; NP_001015037.1; NM_001015037.1.
DR   AlphaFoldDB; Q58FK9; -.
DR   SMR; Q58FK9; -.
DR   STRING; 10116.ENSRNOP00000059667; -.
DR   iPTMnet; Q58FK9; -.
DR   PhosphoSitePlus; Q58FK9; -.
DR   SwissPalm; Q58FK9; -.
DR   GeneID; 541589; -.
DR   KEGG; rno:541589; -.
DR   AGR; RGD:1359262; -.
DR   CTD; 56267; -.
DR   RGD; 1359262; Kyat3.
DR   InParanoid; Q58FK9; -.
DR   OrthoDB; 176869at2759; -.
DR   PhylomeDB; Q58FK9; -.
DR   BRENDA; 2.6.1.7; 5301.
DR   UniPathway; UPA00334; UER00726.
DR   PRO; PR:Q58FK9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0047804; F:cysteine-S-conjugate beta-lyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047315; F:kynurenine-glyoxylate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0016212; F:kynurenine-oxoglutarate transaminase activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISO:RGD.
DR   GO; GO:0006520; P:amino acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   GO; GO:0070189; P:kynurenine metabolic process; ISS:UniProtKB.
DR   GO; GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway.
DR   CDD; cd00609; AAT_like; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR051326; Kynurenine-oxoglutarate_AT.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   PANTHER; PTHR43807; FI04487P; 1.
DR   PANTHER; PTHR43807:SF6; KYNURENINE--OXOGLUTARATE TRANSAMINASE 3; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Aminotransferase; Lyase; Pyridoxal phosphate;
KW   Reference proteome; Transferase.
FT   CHAIN           1..454
FT                   /note="Kynurenine--oxoglutarate transaminase 3"
FT                   /id="PRO_0000287706"
FT   BINDING         71
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16773"
FT   BINDING         218
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16773"
FT   BINDING         429
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q16773"
FT   MOD_RES         116
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q6YP21"
FT   MOD_RES         116
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q71RI9"
FT   MOD_RES         280
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q16773"
SQ   SEQUENCE   454 AA;  51044 MW;  77F70B4DEC32D9AC CRC64;
     MLLAQRRLFS LGCRAKPIKT IYSSKVLGLS TSAKMALRFK NAKRIEGLDQ NVWVEFTKLA
     ADPSVVNLGQ GFPDITLPSY VQEELSKAAF IDNLNQYTRG FGHPSLVKAL SCLYGKIYQK
     QIDPNEEILV TVGGYGSLFN AIQGLVDPGD EVIIMVPFYD CYEPMVKMAG AVPVFIPLRS
     KRTDGMKWTS SDWTFNPQEL ESKFSSKTKA IILNTPHNPI GKVYTREELQ VIADLCIKHD
     TLCISDEVYE WLVYTGHKHI KVASLPGMWD RTLTIGSAGK TFSVTGWKLG WSIGPGHLIK
     HLRTVQQTSV YTCATPLQAA LAEAFWIDIK RMDDPECYFN SLPKELEVKR DRMACLLNSV
     GLKPIIPDGG YFIIADVSSL GVDLSDVKSD EPYDYKFVKW MTKNKKLSAI PVSAFCDSES
     KPHFEKLVRF CFIKKDSTLD AAEEIFRTWN SRKS
//
